Related Experiment Video
Updated: Jul 17, 2026

Heuristic Mining of Hierarchical Genotypes and Accessory Genome Loci in Bacterial Populations
Published on: December 7, 2021
Distribution of emm genotypes among group A streptococcus isolates from patients with severe invasive streptococcal
T Ikebe1, K Hirasawa, R Suzuki
1Department of Bacteriology, National Institute of Infectious Diseases, Tokyo, Japan.
Abstract:
We surveyed emm genotypes of group A streptococcus (GAS) isolates from patients with severe invasive streptococcal infections during 2001-2005 and compared their prevalence with that of the preceding 5 years. Genotype emm1 remained dominant throughout 2001 to 2005, but the frequency rate of this type decreased compared with the earlier period. Various other emm types have appeared in recent years indicating alterations in the prevalent strains causing severe invasive streptococcal infections. The cover of the new 26-valent GAS vaccine fell from 93.5% for genotypes of isolates from 1996-2000 to 81.8% in 2001-2005.
Insights
Group A Streptococcus (GAS) emm genotype 1 remained dominant but decreased in prevalence. Emerging emm types altered vaccine coverage for invasive streptococcal infections.
Area of Science:
- Microbiology
- Epidemiology
- Infectious Diseases
Background:
- Group A Streptococcus (GAS) is a significant human pathogen.
- emm genotypes are key determinants of GAS epidemiology and vaccine efficacy.
- Monitoring emm genotype prevalence is crucial for public health.
Purpose of the Study:
- To analyze trends in emm genotypes of GAS isolates from severe invasive infections between 2001-2005.
- To compare current emm genotype prevalence with the preceding 5-year period.
- To assess the impact of changing emm genotypes on the coverage of a 26-valent GAS vaccine.
Main Methods:
- Retrospective analysis of GAS isolates from patients with severe invasive infections.
- emm genotyping of isolates.
- Comparison of genotype frequencies between two 5-year periods (1996-2000 and 2001-2005).
Main Results:
- emm1 remained the dominant genotype during 2001-2005.
- The frequency of emm1 decreased compared to the 1996-2000 period.
- An increase in the diversity of emm genotypes was observed.
- The projected coverage of a 26-valent GAS vaccine decreased from 93.5% (1996-2000) to 81.8% (2001-2005).
Conclusions:
- While emm1 remains prevalent, shifts in emm genotype distribution are occurring in invasive GAS strains.
- These changes have led to a reduced effectiveness of the current 26-valent GAS vaccine.
- Continued surveillance of emm genotypes is essential for adapting prevention and treatment strategies.
Related Concept Videos
Bacterial Gastroenteritis
Streptococcal Pharyngitis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
